Correction of displays vazopatii in patients with arterial hypertension and metabolic syndrome with medical complex losartan

Purpose - to explore the possibilities of correcting violations antiplatelet activity of the vascular wall in hypertensive patients with metabolic syndrome using a set of losartan, pioglitazone and non-drug treatments. It was found that the investigated complex treatment in these patients within 4 months of treatment improves not fully normalizing antiaggregatory activity of the vascular wall. The achieved results are unstable and tend to a partial loss at non-strict observance of non-pharmacological correction, despite continued strong medication.